Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma

Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of non-small cell lung cancer (NSCLC) for which there is currently no recognized treatment. Recently, favorable immune checkpoint blockade responses have been observed in PPLELC. This study aimed to review the effects of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zuohong, Xian, Xinghong, Wang, Ke, Cheng, Deyun, Li, Weimin, Chen, Bojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110193/
https://www.ncbi.nlm.nih.gov/pubmed/33981599
http://dx.doi.org/10.3389/fonc.2021.626566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110193/
https://www.ncbi.nlm.nih.gov/pubmed/33981599
http://dx.doi.org/10.3389/fonc.2021.626566

Ejemplares similares